IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

REBECCA HOLDSWORTH

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care

NPI
1770250474
CMS profile
11106412
Location
WELLS, ME

General Payments · PY2021–2024

$2,903.82

  • Reported across 123 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$867.29

48 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Primary Care ME All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $867.29 48

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Boehringer Ingelheim Pharmaceuticals, Inc. $195.40 8
NOVARTIS PHARMACEUTICALS CORPORATION $157.45 15
Kiniksa Pharmaceuticals International, plc $105.50 5
Merck Sharp & Dohme Corporation $79.28 4
Lexicon Pharmaceuticals, Inc. $74.05 4
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $65.88 3
PFIZER INC. $46.18 2
Amgen Inc. $42.81 2
Acerta Pharma LLC $27.45 1
Bayer HealthCare Pharmaceuticals Inc. $19.89 1
Takeda Pharmaceuticals U.S.A., Inc. $19.16 1
Janssen Pharmaceuticals, Inc $17.44 1
E.R. Squibb & Sons, L.L.C. $16.80 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $93.38 1
PY2022 $568.22 16
PY2023 $1,374.93 58
PY2024 $867.29 48

Payment records · PY2024 (48)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $17.73 02/19/2024 Food and Beverage Undisputed 01/23/2026 1117279550 CMS
Amgen Inc. $25.08 11/19/2024 Food and Beverage Undisputed 01/23/2026 1117580624 CMS
AstraZeneca Pharmaceuticals LP $27.45 11/25/2024 Food and Beverage Undisputed 01/23/2026 1104376427 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.89 10/24/2024 Food and Beverage Undisputed 01/23/2026 1086358026 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $33.09 01/18/2024 Food and Beverage Undisputed 01/23/2026 1118146628 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.09 02/22/2024 Food and Beverage Undisputed 01/23/2026 1118146634 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $8.98 05/09/2024 Food and Beverage Undisputed 01/23/2026 1118146632 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $32.09 05/30/2024 Food and Beverage Undisputed 01/23/2026 1118146626 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.12 06/27/2024 Food and Beverage Undisputed 01/23/2026 1118146630 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $26.11 09/04/2024 Food and Beverage Undisputed 01/23/2026 1118146624 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.00 10/01/2024 Food and Beverage Undisputed 01/23/2026 1118146622 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.92 12/18/2024 Food and Beverage Undisputed 01/23/2026 1118146636 CMS
E.R. Squibb & Sons, L.L.C. $16.80 05/09/2024 Food and Beverage Undisputed 01/23/2026 1101617998 CMS
Janssen Pharmaceuticals, Inc $17.44 02/02/2024 Food and Beverage Undisputed 01/23/2026 1078047820 CMS
Kiniksa Pharmaceuticals International, plc $21.78 01/11/2024 Food and Beverage Undisputed 01/23/2026 1154856663 CMS
Kiniksa Pharmaceuticals International, plc $22.11 03/06/2024 Food and Beverage Undisputed 01/23/2026 1154856659 CMS
Kiniksa Pharmaceuticals International, plc $22.18 03/12/2024 Food and Beverage Undisputed 01/23/2026 1154856661 CMS
Kiniksa Pharmaceuticals International, plc $15.67 04/17/2024 Food and Beverage Undisputed 01/23/2026 1154856653 CMS
Kiniksa Pharmaceuticals International, plc $23.76 04/29/2024 Food and Beverage Undisputed 01/23/2026 1154856655 CMS
Lexicon Pharmaceuticals, Inc. $20.40 03/18/2024 Food and Beverage Undisputed 01/23/2026 1081700815 CMS
Lexicon Pharmaceuticals, Inc. $16.74 05/10/2024 Food and Beverage Undisputed 01/23/2026 1081700809 CMS
Lexicon Pharmaceuticals, Inc. $18.31 05/29/2024 Food and Beverage Undisputed 01/23/2026 1081700811 CMS
Lexicon Pharmaceuticals, Inc. $18.60 06/06/2024 Food and Beverage Undisputed 01/23/2026 1081700813 CMS
Merck Sharp & Dohme LLC $14.41 01/09/2024 Food and Beverage Undisputed 01/23/2026 1141933769 CMS
Merck Sharp & Dohme LLC $19.04 02/20/2024 Food and Beverage Undisputed 01/23/2026 1141730222 CMS
Merck Sharp & Dohme LLC $18.79 03/19/2024 Food and Beverage Undisputed 01/23/2026 1141730216 CMS
Merck Sharp & Dohme LLC $27.04 05/06/2024 Food and Beverage Undisputed 01/23/2026 1141730048 CMS
Novartis Pharmaceuticals Corporation $4.74 01/12/2024 Food and Beverage Undisputed 01/23/2026 1086845281 CMS
Novartis Pharmaceuticals Corporation $15.94 02/13/2024 Food and Beverage Undisputed 01/23/2026 1086845283 CMS
Novartis Pharmaceuticals Corporation $8.30 02/13/2024 Food and Beverage Undisputed 01/23/2026 1086845285 CMS
Novartis Pharmaceuticals Corporation $4.78 03/14/2024 Food and Beverage Undisputed 01/23/2026 1086845289 CMS
Novartis Pharmaceuticals Corporation $17.64 03/14/2024 Food and Beverage Undisputed 01/23/2026 1086845295 CMS
Novartis Pharmaceuticals Corporation $15.38 05/01/2024 Food and Beverage Undisputed 01/23/2026 1086845297 CMS
Novartis Pharmaceuticals Corporation $13.07 05/01/2024 Food and Beverage Undisputed 01/23/2026 1086845299 CMS
Novartis Pharmaceuticals Corporation $5.65 05/23/2024 Food and Beverage Undisputed 01/23/2026 1086845303 CMS
Novartis Pharmaceuticals Corporation $6.69 06/26/2024 Food and Beverage Undisputed 01/23/2026 1086845307 CMS
Novartis Pharmaceuticals Corporation $9.30 06/26/2024 Food and Beverage Undisputed 01/23/2026 1086845309 CMS
Novartis Pharmaceuticals Corporation $15.12 07/26/2024 Food and Beverage Undisputed 01/23/2026 1086845311 CMS
Novartis Pharmaceuticals Corporation $14.72 09/10/2024 Food and Beverage Undisputed 01/23/2026 1086845313 CMS
Novartis Pharmaceuticals Corporation $18.90 09/19/2024 Food and Beverage Undisputed 01/23/2026 1086845317 CMS
Novartis Pharmaceuticals Corporation $1.90 09/19/2024 Food and Beverage Undisputed 01/23/2026 1086845319 CMS
Novartis Pharmaceuticals Corporation $5.32 10/11/2024 Food and Beverage Undisputed 01/23/2026 1086845321 CMS
PFIZER INC. $17.29 07/30/2024 Food and Beverage Undisputed 01/23/2026 1131766002 CMS
PFIZER INC. $28.89 09/30/2024 Food and Beverage Undisputed 01/23/2026 1131941693 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.16 10/07/2024 Food and Beverage Undisputed 01/23/2026 1137764627 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $25.66 06/20/2024 Food and Beverage Undisputed 01/23/2026 1080685806 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $19.59 10/10/2024 Food and Beverage Undisputed 01/23/2026 1080685934 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $20.63 12/04/2024 Food and Beverage Undisputed 01/23/2026 1080686004 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.